ENvue Medical (FEED) Gross Profit (2014 - 2026)

ENvue Medical (FEED) has reported Gross Profit for 13 consecutive years, with -$266000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit fell 660.0% year-over-year to -$266000.0 in Q2 2026; TTM through Jun 2026 was -$502000.0, a 166.93% decrease from a year earlier, with the FY2025 full-year figure at $153000.0, down 89.85% from the prior year.
• Gross Profit was -$266000.0 for Q2 2026 at ENvue Medical, down from -$55000.0 in the prior quarter.
• Over five years, Gross Profit peaked at $737000.0 in Q4 2023 and troughed at -$370000.0 in Q4 2025.
• A 5-year average of $169111.1 and a median of $202500.0 in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit jumped 345.67% in 2023 and slumped 660.0% in 2026, its largest moves.
• Over 5 years, Gross Profit stood at -$300000.0 in 2022, then soared by 345.67% to $737000.0 in 2023, then slumped by 61.6% to $283000.0 in 2024, then tumbled by 230.74% to -$370000.0 in 2025, then increased by 28.11% to -$266000.0 in 2026.
• The last three Gross Profit figures came in at -$266000.0 (Q2 2026), -$55000.0 (Q1 2026), and -$370000.0 (Q4 2025), per Business Quant data.